Ascension Technology Corporation has been acquired by Roper Industries, Inc.
July 2012 — The private shareholders of Ascension Technology Corporation have sold all assets of the company to Roper Industries, Inc. for US$19 million.
Ascension Technology Corporation manufactures 3D magnetic tracking systems for image-guided navigation for minimal invasive surgery or diagnostic and therapeutic purposes. This allows for non-radiating navigation to the internal targets, such as tumors.
Roper Industries, Inc. designs, manufactures and distributes radio frequency products and services, industrial technology products, energy systems and controls, and medical and scientific imaging products and software.
Our role in the transaction
Oaklins' team in Dallas initiated this transaction, advised the seller and assisted in its closing. Oaklins' team in Japan was also involved in this transaction.
Talk to the deal team
Bryan Livingston
Oaklins Capital Alliance
Related deals
Life & Mobility has attracted investor Bolster Investment Partners
Life & Mobility, a leading developer and manufacturer of premium mobility and rehabilitation solutions, has welcomed Bolster Investment Partners as a new shareholder. The partnership provides Life & Mobility with a strong long-term partner to support the company’s next phase of growth, with a continued focus on product innovation, strengthening its leading market position and further international expansion. The company’s mission remains to enhance the mobility, independence and quality of life of end users through innovative, sustainable and circular mobility solutions designed for multiple life cycles.
Learn moreAsana Gruppe has sold selected outpatient service areas to Luzerner Kantonsspital
Luzerner Kantonsspital (LUKS) has acquired key parts of Asana Spital Menziken AG’s outpatient services from Asana Gruppe AG, including its ambulance service, primary care practice and ambulatory care center. The transaction supports the long-term continuity of local medical care in the Swiss Wynen and Seetal regions and ensures these services remain available close to patients’ homes.
Learn moreLaboratoires Herbolistique has received a majority investment from Yotta Capital Partners and co-investors
Laboratoires Herbolistique has received a majority investment from Yotta Capital Partners alongside co-investors Ouest Croissance, Sodero and CE IDF, with Bpifrance, Océans Participations and the management team reinvesting.
Learn more